|
1
|
Renna NF, de Las Heras N and Miatello RM:
Pathophysiology of vascular remodeling in hypertension. Int J
Hypertens. 2013:8083532013.PubMed/NCBI
|
|
2
|
Kearney PM, Whelton M, Reynolds K, Muntner
P, Whelton PK and He J: Global burden of hypertension: Analysis of
worldwide data. Lancet. 365:217–223. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chiong JR: Controlling hypertension from a
public health perspective. Int J Cardiol. 127:151–156. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bloch MJ: Worldwide prevalence of
hypertension exceeds 1.3 billion. J Am Soc Hypertens. 10:753–754.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun F, Zhang K, Li X, He N, Zhao J and Qiu
C: Effects of angiotensin-converting enzyme gene and environment
interaction on essential hypertension in the Han nationality. Wei
Sheng Yan Jiu. 46:378–383. 2017.In Chinese.
|
|
6
|
Shah SFA, Iqbal T, Qamar R, Rafiq MA and
Hussain S: ARG1 gene polymorphisms and their association in
individuals with essential hypertension: A case-control study. DNA
Cell Biol. 37:609–616. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li C, Samaranayake NR, Ong KL, Wong HK and
Cheung BM: Is human cytomegalovirus infection associated with
hypertension? The United States National Health and Nutrition
Examination Survey 1999-2002. PLoS One. 7:e397602012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun HJ, Ren XS, Xiong XQ, Chen YZ, Zhao
MX, Wang JJ, Zhou YB, Han Y, Chen Q, Li YH, et al: NLRP3
inflammasome activation contributes to VSMC phenotypic
transformation and proliferation in hypertension. Cell Death Dis.
8:e30742017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hijmans JG, Diehl KJ, Bammert TD, Kavlich
PJ, Lincenberg GM, Greiner JJ, Stauffer BL and DeSouza CA:
Association between hypertension and circulating vascular-related
microRNAs. J Hum Hypertens. 32:440–447. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Murphy E, Yu D, Grimwood J, Schmutz J,
Dickson M, Jarvis MA, Hahn G, Nelson JA, Myers RM and Shenk TE:
Coding potential of laboratory and clinical strains of human
cytomegalovirus. Proc Natl Acad Sci USA. 100:14976–14981. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gatherer D, Seirafian S, Cunningham C,
Holton M, Dargan DJ, Baluchova K, Hector RD, Galbraith J, Herzyk P,
Wilkinson GW and Davison AJ: High-resolution human cytomegalovirus
transcriptome. Proc Natl Acad Sci USA. 108:19755–19760. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cannon MJ, Schmid DS and Hyde TB: Review
of cytomegalo-virus seroprevalence and demographic characteristics
associated with infection. Rev Med Virol. 20:202–213. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang M, Yang Y, Yang X and Cai J: Human
cytomegalovirus infection is a novel etiology for essential
hypertension. Med Hypotheses. 76:682–684. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Emery VC: Recent progress in understanding
pathogenesis and control. QJM. 105:401–405. 2012. View Article : Google Scholar
|
|
15
|
Fu M, Gao Y, Zhou Q, Zhang Q, Peng Y, Tian
K, Wang J and Zheng X: Human cytomegalovirus latent infection
alters the expression of cellular and viral microRNA. Gene.
536:272–278. 2014. View Article : Google Scholar
|
|
16
|
Leite-Moreira AM, Lourenço AP,
Falcão-Pires I and Leite-Moreira AF: Pivotal role of microRNAs in
cardiac physiology and heart failure. Drug Discov Today.
18:1243–1249. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018. View Article : Google Scholar :
|
|
18
|
Li X, Wei Y and Wang Z: microRNA-21 and
hypertension. Hypertens Res. 41:649–661. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huo KG, Richer C, Berillo O, Mahjoub N,
Fraulob-Aquino JC, Barhoumi T, Ouerd S, Coelho SC, Sinnett D,
Paradis P and Schiffrin EL: miR-431-5p knockdown protects against
angiotensin II-induced hypertension and vascular injury.
Hypertension. 73:1007–1017. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li FJ, Zhang CL, Luo XJ, Peng J and Yang
TL: Involvement of the MiR-181b-5p/HMGB1 pathway in Ang II-induced
phenotypic transformation of smooth muscle cells in hypertension.
Aging Dis. 10:231–248. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen K, Xu L, Chen D, Tang W and Huang Y:
Human cytomeg-alovirus-encoded miR-UL112 contributes to
HCMV-mediated vascular diseases by inducing vascular endothelial
cell dysfunction. Virus Genes. 54:172–181. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang S, Liu L, Wang R, Tuo H, Guo Y, Yi
L, Wang D and Wang J: miR-138 promotes migration and tube formation
of human cytomegalovirus-infected endothelial cells through the
SIRT1/p-STAT3 pathway. Arch Virol. 162:2695–2704. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pfeffer S, Sewer A, Lagos-Quintana M,
Sheridan R, Sander C, Grässer FA, van Dyk LF, Ho CK, Shuman S,
Chien M, et al: Identification of microRNAs of the herpesvirus
family. Nat Methods. 2:269–276. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meshesha MK, Veksler-Lublinsky I, Isakov
O, Reichenstein I, Shomron N, Kedem K, Ziv-Ukelson M, Bentwich Z
and Avni YS: The microRNA transcriptome of human cytomegalovirus
(HCMV). Open Virol J. 6:38–48. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang L, Yu J and Liu Z: MicroRNAs
expressed by human cytomegalovirus. Virol J. 17:342020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Elliott EI and Sutterwala FS: Initiation
and perpetuation of NLRP3 inflammasome activation and assembly.
Immunol Rev. 265:35–52. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Krishnan SM, Sobey CG, Latz E, Mansell A
and Drummond GR: IL-1β and IL-18: Inflammatory markers or mediators
of hyper-tension? Br J Pharmacol. 171:5589–5602. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu D, Zeng X, Li X, Mehta JL and Wang X:
Role of NLRP3 inflammasome in the pathogenesis of cardiovascular
diseases. Basic Res Cardiol. 113:52018. View Article : Google Scholar
|
|
29
|
Intengan HD and Schiffrin EL: Vascular
remodeling in hypertension: Roles of apoptosis, inflammation, and
fibrosis. Hypertension. 38:581–587. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song J, Yang S, Yin R, Xiao Q, Ma A and
Pan X: MicroRNA-181a regulates the activation of the NLRP3
inflammatory pathway by targeting MEK1 in THP-1 macrophages
stimulated by ox-LDL. J Cell Biochem. 120:13640–13650. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Wu Q, Yu J, Cao X and Xu Z:
miR-125a-5p inhibits the expression of NLRP3 by targeting CCL4 in
human vascular smooth muscle cells treated with ox-LDL. Exp Ther
Med. 18:1645–1652. 2019.PubMed/NCBI
|
|
32
|
Ren XS, Tong Y, Ling L, Chen D, Sun HJ,
Zhou H, Qi XH, Chen Q, Li YH, Kang YM and Zhu GQ: NLRP3 gene
deletion attenuates Angiotensin II-induced phenotypic
transformation of vascular smooth muscle cells and vascular
remodeling. Cell Physiol Biochem. 44:2269–2280. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang R, Wu W, Li W, Huang S, Li Z, Liu R,
Shan Z, Zhang C, Li W and Wang S: Activation of NLRP3 inflammasome
promotes foam cell formation in vascular smooth muscle cells and
atherogenesis via HMGB1. J Am Heart Assoc. 7:e0085962018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yunzhong S, Xi D, Zhang X, Zhen H, Tang N,
YongMin L, Wang LM, Tang Y, Zhong H and He F: Screening and
validation of differentially expressed microRNAs and target genes
in hypertensive mice induced by cytomegalovirus infection. Biosci
Rep. BSR202023872020.
|
|
35
|
Yeager ME, Belchenko DD, Nguyen CM, Colvin
KL, Ivy DD and Stenmark KR: Endothelin-1, the unfolded protein
response, and persistent inflammation: Role of pulmonary artery
smooth muscle cells. Am J Respir Cell Mol Biol. 46:14–22. 2012.
View Article : Google Scholar :
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
37
|
Shiao YH, Palli D, Caporaso NE, Alvord WG,
Amorosi A, Nesi G, Saieva C, Masala G, Fraumeni JF Jr and Rice JM:
Genetic and immunohistochemical analyses of p53 independently
predict regional metastasis of gastric cancers. Cancer Epidemiol
Biomarkers Prev. 9:631–633. 2000.PubMed/NCBI
|
|
38
|
Touyz RM and Schiffrin EL: Role of
endothelin in human hyper-tension. Can J Physiol Pharmacol.
81:533–541. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Roberts ET, Haan MN, Dowd JB and Aiello
AE: Cytomegalovirus antibody levels, inflammation, and mortality
among elderly Latinos over 9 years of follow-up. Am J Epidemiol.
172:363–371. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ward R and Ergul A: Relationship of
endothelin-1 and NLRP3 inflammasome activation in HT22 hippocampal
cells in diabetes. Life Sci. 159:97–103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Reddehase MJ and Lemmermann NAW: Cellular
reservoirs of latent cytomegaloviruses. Med Microbiol Immunol.
208:391–403. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cheng J, Ke Q, Jin Z, Wang H, Kocher O,
Morgan JP, Zhang J and Crumpacker CS: Cytomegalovirus infection
causes an increase of arterial blood pressure. PLoS Pathog.
5:e10004272009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bruno RM, Duranti E, Ippolito C, Segnani
C, Bernardini N, Di Candio G, Chiarugi M, Taddei S and Virdis A:
Different impact of essential hypertension on structural and
functional age-related vascular changes. Hypertension. 69:71–78.
2017. View Article : Google Scholar
|
|
44
|
Dinh QN, Drummond GR, Kemp-Harper BK, Diep
H, De Silva TM, Kim HA, Vinh A, Robertson AAB, Cooper MA, Mansell
A, et al: Pressor response to angiotensin II is enhanced in aged
mice and associated with inflammation, vasoconstriction and
oxidative stress. Aging (Albany NY). 9:1595–1606. 2017. View Article : Google Scholar
|
|
45
|
Baumbach GL and Ghoneim S: Vascular
remodeling in hyper-tension. Scanning Microsc. 7:137–143. 1993.
|
|
46
|
Laurent S and Boutouyrie P: The structural
factor of hypertension: Large and small artery alterations. Circ
Res. 116:1007–1021. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang GC, Kao WH, Murakami P, Xue QL, Chiou
RB, Detrick B, McDyer JF, Semba RD, Casolaro V, Walston JD and
Fried LP: Cytomegalovirus infection and the risk of mortality and
frailty in older women: A prospective observational cohort study.
Am J Epidemiol. 171:1144–1152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li Z, Tang Y, Tang N, Feng Q, Zhong H, Liu
YM, Wang LM and He F: High anti-human cytomegalovirus antibody
levels are associated with the progression of essential
hypertension and target organ damage in Han Chinese population.
PLoS One. 12:e01814402017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mulvany MJ: Small artery remodeling and
significance in the development of hypertension. News Physiol Sci.
17:105–109. 2002.PubMed/NCBI
|
|
50
|
Li S, Zhu J, Zhang W, Chen Y, Zhang K,
Popescu LM, Ma X, Lau WB, Rong R, Yu X, et al: Signature microRNA
expression profile of essential hypertension and its novel link to
human cytomegalovirus infection. Circulation. 124:175–184. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tang N, Li JW, Liu YM, Zhong H, Wang LM,
Deng FM, Qu YY, Hui J, Cheng J, Tang B, et al: Human
cytomegalovirus infection is associated with essential hypertension
in Kazakh and Han Chinese populations. Med Sci Monit. 20:2508–2519.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bronze-da-Rocha E: MicroRNAs expression
profiles in cardio-vascular diseases. Biomed Res Int.
2014:9854082014. View Article : Google Scholar
|
|
53
|
Song X, Shan D, Chen J and Jing Q: miRNAs
and lncRNAs in vascular injury and remodeling. Sci China Life Sci.
57:826–835. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jeppesen PL, Christensen GL, Schneider M,
Nossent AY, Jensen HB, Andersen DC, Eskildsen T, Gammeltoft S,
Hansen JL and Sheikh SP: Angiotensin II type 1 receptor signal-ling
regulates microRNA differentially in cardiac fibroblasts and
myocytes. Br J Pharmacol. 164:394–404. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Xie C, Zhang J and Chen YE: Chapter
Fifteen-MicroRNA and Vascular Smooth Muscle Cells. Elsevier Science
& Technology; 2011
|
|
56
|
Kang H and Hata A: MicroRNA regulation of
smooth muscle gene expression and phenotype. Curr Opin Hematol.
19:224–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Robinson HC and Baker AH: How do microRNAs
affect vascular smooth muscle cell biology? Curr Opin Lipidol.
23:405–411. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Li Y, Ren W, Wang X, Yu X, Cui L, Li X,
Zhang X and Shi B: MicroRNA-150 relieves vascular remodeling and
fibrosis in hypoxia-induced pulmonary hypertension. Biomed
Pharmacother. 109:1740–1749. 2019. View Article : Google Scholar
|
|
59
|
Bostick B, Ghosh A, Yue Y, Long C and Duan
D: Systemic AAV-9 transduction in mice is influenced by animal age
but not by the route of administration. Gene Ther. 14:1605–1609.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Keller S, Karaa A, Paxian M, Clemens MG
and Zhang JX: Inhibition of endothelin-1-mediated up-regulation of
iNOS by bosentan ameliorates endotoxin-induced liver injury in
cirrhosis. Shock. 25:306–313. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Khalil RA: Modulators of the vascular
endothelin receptor in blood pressure regulation and hypertension.
Curr Mol Pharmacol. 4:176–186. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
D'Orléans-Juste P, Akide Ndunge OB,
Desbiens L, Tanowitz HB and Desruisseaux MS: Endothelins in
inflammatory neurological diseases. Pharmacol Ther. 194:145–160.
2019. View Article : Google Scholar :
|
|
64
|
Xu H, Lin L and Yuan WJ: Antiarrhythmic
effect of endothelin-A receptor antagonist on acute ischemic
arrhythmia in isolated rat heart. Acta Pharmacol Sin. 24:37–44.
2003.PubMed/NCBI
|
|
65
|
Elmarakby AA, Loomis ED, Pollock JS and
Pollock DM: NADPH oxidase inhibition attenuates oxidative stress
but not hypertension produced by chronic ET-1. Hypertension.
45:283–287. 2005. View Article : Google Scholar
|
|
66
|
Loomis ED, Sullivan JC, Osmond DA, Pollock
DM and Pollock JS: Endothelin mediates superoxide production and
vasoconstriction through activation of NADPH oxidase and uncoupled
nitric-oxide synthase in the rat aorta. J Pharmacol Exp Ther.
315:1058–1064. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Schmidt RL and Lenz LL: Distinct licensing
of IL-18 and IL-1β secretion in response to NLRP3 inflammasome
activation. PLoS One. 7:e451862012. View Article : Google Scholar
|
|
68
|
Pirhonen J, Sareneva T, Kurimoto M,
Julkunen I and Matikainen S: Virus infection activates IL-1 beta
and IL-18 production in human macrophages by a caspase-1-dependent
pathway. J Immunol. 162:7322–7329. 1999.PubMed/NCBI
|
|
69
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
